Bingnan Guo

942 citations
12 papers · 780 indexed · h-index 7
Topics
Nanoparticle-Based Drug Delivery (3 papers)Herpesvirus Infections and Treatments (2 papers)Immune Response and Inflammation (2 papers)
Partner nations
ChinaUnited States

In The Last Decade

Bingnan Guo

11 papers receiving 774 citations

Peers

Bingnan Guo
Comparison fields: 5 of 77
  • Biomaterials 519
  • Biomedical Engineering 291
  • Molecular Biology 264
  • Organic Chemistry 218
  • Polymers and Plastics 176
Replace Yusi Lai with:
Yusi Lai China
Shivanjali Joshi-Barr United States
Chengyuan Zhang China
José Portilla‐Arias United States
Jingxia Gu China
Ran Ji China
Nolwenn Lautram France
Xikuang Yao China
Yi‐Ting Chiang Taiwan
Mengtan Cai China
Bingnan Guo relative to Yusi Lai China Yusi Lai's profile →
Citations per field
00.5×1.5×
Yusi Lai · 1×
Citations per year

Countries citing papers authored by Bingnan Guo

Since Specialization
Citations

This map shows the geographic impact of Bingnan Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bingnan Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bingnan Guo more than expected).

Fields of papers citing papers by Bingnan Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bingnan Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bingnan Guo. The network helps show where Bingnan Guo may publish in the future.

Co-authorship network of co-authors of Bingnan Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Bingnan Guo. A scholar is included among the top collaborators of Bingnan Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bingnan Guo. Bingnan Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
#WorkIndexed citations
1 6
2
Smad7 suppresses melanoma lung metastasis by impairing Tregs migration to the tumor microenvironment.
4
3 9
4 3
5
Classification of online loan based on improved cost-sensitive decision tree
1
6 42
7 23
8 18
9 1
10 0
11 279
12 394

About Bingnan Guo

Bingnan Guo is a scholar working on Geriatrics and Gerontology, Biomaterials and Critical Care and Intensive Care Medicine, having authored 12 papers that have together received 780 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (3 papers), Herpesvirus Infections and Treatments (2 papers) and Immune Response and Inflammation (2 papers). The work is most often cited by research in Biomaterials (519 citations), Polymers and Plastics (176 citations) and Surfaces, Coatings and Films (74 citations). Bingnan Guo has collaborated with scholars based in China and United States. Frequent co-authors include Ru Cheng, Zhiyuan Zhong, Huanli Sun, Fenghua Meng, Haiyan Liu, Xiaoqing Li, Xianliang Yan, Tie Xu, Li Tan and Rong Hua. Their work appears in journals such as PLoS ONE, Biomaterials and Journal of Controlled Release.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026